Cardiovascular disease in diabetes, beyond glucose

被引:117
|
作者
Eckel, Robert H. [1 ,2 ]
Bornfeldt, Karin E. [3 ,4 ]
Goldberg, Ira J. [5 ]
机构
[1] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Div Cardiol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
[4] Univ Washington, Dept Lab Med & Pathol, Med Diabet Inst, Seattle, WA 98195 USA
[5] NYU, Div Endocrinol Diabet & Metab, Grossman Sch Med, New York, NY USA
关键词
CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; PRESSURE-LOWERING TREATMENT; INTENSIVE GLYCEMIC CONTROL; IMPAIRED FASTING GLUCOSE; SYSTOLIC BLOOD-PRESSURE; ALL-CAUSE MORTALITY; 10-YEAR FOLLOW-UP; INSULIN-RESISTANCE; RISK-FACTORS;
D O I
10.1016/j.cmet.2021.07.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
引用
收藏
页码:1519 / 1545
页数:27
相关论文
共 50 条
  • [11] Cardiovascular disease in diabetes
    Zhang, P. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (15) : 2205 - 2214
  • [12] Diabetes Mellitus, Cardiovascular Risk, and HIV Disease
    Grinspoon, Steven
    CIRCULATION, 2009, 119 (06) : 770 - 772
  • [13] Epidemiological associations between on and cardiovascular disease and diabetes
    Basuli, Debargha
    Stevens, Richard G.
    Torti, Frank M.
    Torti, Suzy V.
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [14] Prevention of Cardiovascular Disease in Type 1 Diabetes
    Manrique-Acevedo, Camila
    Hirsch, Irl B.
    Eckel, Robert H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (13): : 1207 - 1217
  • [15] Statins and beyond: Concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes
    Standl, Eberhard
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (02): : 99 - 114
  • [16] Cardiovascular disease and intensive glucose lowering in type 2 diabetes
    Younis, N.
    Soran, H.
    Hassanein, M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2009, 102 (04) : 293 - 296
  • [17] Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
    Hanssen, Nordin M. J.
    Kraakman, Michael J.
    Flynn, Michelle C.
    Nagareddy, Prabhakara R.
    Schalkwijk, Casper G.
    Murphy, Andrew J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [18] Cardiovascular Disease and Dyslipidemia: Beyond LDL
    Poess, Janine
    Custodis, Florian
    Werner, Christian
    Weingaertner, Oliver
    Boehm, Michael
    Laufs, Ulrich
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 861 - 870
  • [19] Pathogenesis of Cardiovascular Disease in Diabetes
    Haas, Andrea V.
    McDonnell, Marie E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 51 - +
  • [20] The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes
    Gonna, Hanney
    Ray, Kausik K.
    DIABETES OBESITY & METABOLISM, 2019, 21 : 6 - 16